Merck KGaA is backing out of its multiple sclerosis deal with Japan’s Ono Pharmaceutical, deciding not to take the plunge on Phase III development for a drug that would face stiff competition.

…read more

Source: Merck KGaA pulls the plug on Ono’s MS drug as the market crowds


0 No comments